Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 28, 2020

Intuitive Surgical launches $100m venture capital investment fund

US-based Intuitive Surgical, which specialises in minimally invasive care and robotic-assisted surgery, has launched a $100m inaugural investment fund, called Intuitive Ventures.

US-based Intuitive Surgical, which specialises in minimally invasive care and robotic-assisted surgery, has launched a $100m inaugural investment fund, called Intuitive Ventures.

The fund is focused on investment opportunities in digital tools, precision diagnostics, focal therapeutics, and platform technologies.

Intuitive Ventures marks the company’s entry to venture capital space. It will invest in independent ventures in the fields related to minimally invasive care.

Intuitive Ventures president Julian Nikolchev said: “The future of minimally invasive care spans the patient journey from early diagnosis to treatment and beyond.

“Intuitive Ventures is investing in cutting-edge innovation across the continuum of care to bring the future forward.”

Nikolchev, who joined Intuitive Surgical last year, will also continue to serve as the company’s Corporate Development and Strategy senior vice-president.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Nikolchev joins Intuitive Ventures’ director Dr Oliver Keown, who will serve as the director of Intuitive Ventures.

Keown said: “We are value-add investors who leverage access to Intuitive’s unique industry expertise and customer connections.

“Our nimble structure and alignment with the start-ups will empower us to invest early and support our portfolio companies as they pioneer markets.”

Intuitive Ventures has already started deploying capital and is building its portfolio, the company noted.

Last year, Intuitive Surgical received clearance from the Food and Drug Administration (FDA) for the use of its Ion endoluminal system for minimally invasive biopsy in the peripheral lung.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU